Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Center of Research and Innovation, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Blood Transfus. 2023 May;21(3):209-217. doi: 10.2450/2022.0160-22. Epub 2022 Nov 4.
Discriminating individuals with "Asian type DEL" from those who are "true D-negative" (D-) among serologically D- donors/patients in Asia would be very valuable, as clinical outcomes are different in these groups. Here we investigated the molecular basis of D-negativity in Thai blood donors, designing a specific strategy for this purpose.
After routine testing, a total of 1,270 serologically D- blood donors originating from Central, Northeastern and South Thailand underwent analysis of the RHD gene by (i) quantitative multiplex polymerase chain reaction of short fluorescent fragments (QMPSF); (ii) direct sequencing of exon 9 to identify the c.1227G>A variant defining the Asian type DEL allele; and (iii) direct sequencing of the other exons.
The most common observation was whole deletion of the gene (i.e. RHD01N.01; allele frequency: 86.81%), followed by the Asian type DEL allele (RHD01EL.01; 7.60%) and a D-negative hybrid allele (RHD01N.03; 3.46%). Four novel alleles, including one with a 13.1 kilobase-deletion, were identified and characterized. All but one RHD01EL.01 allele carriers (183/184) were C-positive (C+), suggesting that this latter subset may be screened specifically when investigating the c.1227G>A variant, which can be identified with 100% accuracy by a specific Tm-shift genotyping assay.
On the basis of our extensive molecular findings, we have designed a dedicated diagnostic strategy based on Rh C antigen typing followed by a genotyping test. Implementation of this method in all or selected groups of serologically D- donors/patients will contribute to improve the management of transfusion and pregnancy in Thailand.
在亚洲的血清学 D-供体/患者中,区分具有“亚洲型 DEL”的个体和“真正的 D-阴性”(D-)个体非常有价值,因为这两个群体的临床结果不同。在这里,我们调查了泰国献血者 D-阴性的分子基础,为此设计了一种特定的策略。
在常规检测后,来自泰国中部、东北部和南部的 1270 名血清学 D-献血者进行了 RHD 基因分析,采用了以下三种方法:(i)短荧光片段的定量多重聚合酶链反应(QMPSF);(ii)直接测序外显子 9 以鉴定定义亚洲型 DEL 等位基因的 c.1227G>A 变体;(iii)直接测序其他外显子。
最常见的观察结果是基因的完全缺失(即 RHD01N.01;等位基因频率:86.81%),其次是亚洲型 DEL 等位基因(RHD01EL.01;7.60%)和 D-阴性杂合等位基因(RHD01N.03;3.46%)。鉴定并表征了四个新的等位基因,包括一个带有 13.1 千碱基缺失的等位基因。除了一个 RHD01EL.01 等位基因携带者(183/184)为 C+阳性外,所有 RHD*01EL.01 等位基因携带者均为 C+阳性(C+),这表明当调查 c.1227G>A 变体时,可以特异性地筛选该亚组,该变体可以通过特定的 Tm-shift 基因分型检测以 100%的准确率识别。
根据我们广泛的分子发现,我们设计了一种基于 Rh C 抗原分型的专用诊断策略,然后进行基因分型检测。在所有或选定的血清学 D-供体/患者群体中实施该方法,将有助于改善泰国的输血和妊娠管理。